Oral Janus kinase inhibitors in the treatment of atopic dermatitis: A systematic review and meta‐analysis

BACKGROUND: Janus kinase (JAK) inhibitors are being evaluated as promising upcoming treatments for atopic dermatitis (AD). OBJECTIVES: To systematically assess the efficacy of oral JAK inhibitors in patients with AD and provide comparisons among JAK inhibitors. METHODS: A systematic literature revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kevin P., Plante, John, Korte, Jeffrey E., Elston, Dirk M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892442/
https://www.ncbi.nlm.nih.gov/pubmed/36751339
http://dx.doi.org/10.1002/ski2.133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892442/
https://www.ncbi.nlm.nih.gov/pubmed/36751339
http://dx.doi.org/10.1002/ski2.133

Ejemplares similares